EP 2994130 A1 20160316 - FGF MODULATION OF IN VIVO ANTIBODY PRODUCTION AND HUMORAL IMMUNITY
Title (en)
FGF MODULATION OF IN VIVO ANTIBODY PRODUCTION AND HUMORAL IMMUNITY
Title (de)
FGF-MODULATION EINER IN-VIVO-ANTIKÖRPERPRODUKTION UND HUMORALE IMMUNITÄT
Title (fr)
MODULATION DE FGF DANS LA PRODUCTION D'ANTICORPS IN VIVO ET IMMUNITÉ HUMORALE
Publication
Application
Priority
US 2013039758 W 20130506
Abstract (en)
[origin: WO2014182277A1] The invention provides methods for increasing or decreasing antibody production in vivo by inhibiting or promoting the activity of fibroblast growth factor-2 (FGF2) respectively.
IPC 8 full level
A61K 31/405 (2006.01); A61K 31/365 (2006.01); A61K 31/403 (2006.01); A61K 31/4709 (2006.01); A61K 31/496 (2006.01); A61K 31/5025 (2006.01); A61K 31/506 (2006.01); A61K 31/513 (2006.01); A61K 31/519 (2006.01); A61P 43/00 (2006.01)
CPC (source: EP)
A61K 31/365 (2013.01); A61K 31/404 (2013.01); A61K 31/437 (2013.01); A61K 31/47 (2013.01); A61K 31/496 (2013.01); A61K 31/5025 (2013.01); A61K 31/506 (2013.01); A61K 31/517 (2013.01); A61K 31/53 (2013.01); A61K 45/06 (2013.01); A61P 31/04 (2017.12); A61P 31/12 (2017.12); A61P 37/02 (2017.12); A61P 37/04 (2017.12); A61P 43/00 (2017.12)
Designated contracting state (EPC)
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated extension state (EPC)
BA ME
DOCDB simple family (publication)
WO 2014182277 A1 20141113; EP 2994130 A1 20160316; EP 2994130 A4 20170222; JP 2016520060 A 20160711
DOCDB simple family (application)
US 2013039758 W 20130506; EP 13884155 A 20130506; JP 2016512884 A 20130506